SCHEMBL4787116

SCHEMBL4787116

CC(=O)CC(Cl)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10438656 0.78
SCHEMBL6717812 0.78
Methylene Chloride SCHEMBL1395290 0.74 ALDH1A1 (0.48)
Methylene Chloride SCHEMBL4304807 0.74 ALDH1A1 (0.48)
SCHEMBL495774 0.74
SCHEMBL7519154 0.74
Methylene Chloride SCHEMBL7695098 0.74 ALDH1A1 (0.48)
Methylene Chloride SCHEMBL5133360 0.74 ALDH1A1 (0.48)
Methylene Chloride SCHEMBL861591 0.74 ALDH1A1 (0.48)
Methylene Chloride SCHEMBL3630221 0.74 ALDH1A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0790253-B1 Novel crystalline metal-organic microporous materials NALCO CHEMICAL CO (US) 2002-02-06 EP claimed
EP-4688772-A1 BIARYL DERIVATIVES AND RELATED USES Moma Therapeutics, Inc. (US) 2026-02-11 EP disclosed
US-20260015360-A1 BIARYL DERIVATIVES AND RELATED USES MOMA THERAPEUTICS, INC. 2026-01-15 US disclosed
WO-2024211834-A1 BIARYL DERIVATIVES AND RELATED USES MOMA THERAPEUTICS, INC. (US) 2024-10-10 WO disclosed
CN-115043781-A Synthesis method of azoxystrobin product 内蒙古佳瑞米精细化工有限公司 2022-09-13 CN disclosed
CN-112807283-A Novel oral pellet drug delivery system for gastrointestinal tract 江苏集萃新型药物制剂技术研究所有限公司 2021-05-18 CN disclosed
CN-110127925-B Method for recycling mixed salt produced by waste acid treatment 南京大学盐城环保技术与工程研究院 2020-12-08 CN disclosed
CN-106318279-A High-strength CPVC solvent adhesive and preparation method thereof 中国石油化工股份有限公司 2017-01-11 CN disclosed
WO-2008091368-A1 METHODS FOR PRODUCING AND PURIFYING PHENOLPHTHALEIN GENERAL ELECTRIC COMPANY (US) 2008-07-31 WO disclosed
US-20040214783-A1 conjugates, fusion proteins or naked nucleic acids of superantigen (SAg) which produce an anti-tumor responses in transfected host cells (tumor cells, accessory cells or lymphocytes); cancer treatment TERMAN DAVID S (US) 2004-10-28 US disclosed
EP-0247381-A2 5-flurorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1987-12-02 EP disclosed
US-4695673-A Process for the production of acylated 1,3-dicarbonyl compounds STAUFFER CHEMICAL COMPANY (US) 1987-09-22 US disclosed
US-4443619-A MULTISTEP PREPARATION OF MONOPOTASSIUM DIHYDROGEN THREO-EPOXYACONITATE FROM TRANSACONITIC ACID HOFFMANN-LA ROCHE INC. (US) 1984-04-17 US disclosed
EP-0084999-A1 Process for the preparation of organic oligosaccharides, corresponding to fragments of natural muco-polysaccharides, oligosaccharides obtained and their biological applications D.R.O.P.I.C. (Société Civile) (FR) 1983-08-03 EP disclosed
US-4365070-A B-LACTONE INTERMEDIATES THEREOF, ANORECTIC AGENTS FOR TREATMENT OBESITY HOFFMANN-LA ROCHE INC. (US) 1982-12-21 US disclosed
US-4354039-A Chlorocitric acids HOFFMANN-LA ROCHE INC. (US) 1982-10-12 US disclosed
US-4353919-A Analgesic and antipyretic pharmaceutical compositions containing a benzothiazol-2(3H)-one DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1982-10-12 US disclosed
US-4352758-A FROM TRANS-ACONITIC ACID HOFFMANN-LA ROCHE INC. (US) 1982-10-05 US disclosed
US-4340754-A Process for making chlorocitric acid HOFFMANN-LA ROCHE INC. (US) 1982-07-20 US disclosed
US-4312885-A ANORECTIC AGENTS FOR TREATMENT OF OBESITY HOFFMANN-LA ROCHE INC. (US) 1982-01-26 US disclosed